Contribution: Industrial Research Assistance Program – Contributions to Firms
Response Biomedical Corp.
$550,984.00
COVID-19 - Development of a RAMP COVID-19 Antigen Assay
EF 2020-21 · 2020-11-17
Résumé
This project is designed to support the current COVID-19 pandemic by producing a high quality 15 minute RAMP COVID-19 Antigen test. The RAMP platform is based on fluorescence detection & has demonstrated similar performance to PCR in end user settings.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
121519920
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2020-11-17 | 2020-21 | $159,354.00 |
| 1 | 2020-11-17 | 2020-21 | $359,354.00 |
| 2 | 2020-11-17 | 2020-21 | $550,984.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days. The total amended value is 191,630 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 151 jours. La valeur totale des modifications est de 191 630 dollars.
Agreement End Date
2022-05-31
Agreement Number
960033
Agreement Start Date
2020-11-17
Agreement Title
COVID-19 - Development of a RAMP COVID-19 Antigen Assay
Agreement Title (French)
COVID-19 - Mise au point d'un test d'antigène COVID-19 RAMP
Agreement Type
Contribution
Agreement Value
$550,984.00
Amendment Date
2021-11-23
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project is designed to support the current COVID-19 pandemic by producing a high quality 15 minute RAMP COVID-19 Antigen test. The RAMP platform is based on fluorescence detection & has demonstrated similar performance to PCR in end user settings.
Description (French)
Ce projet est conçu pour contribuer à la lutte contre la pandémie actuelle de COVID-19 en produisant un test d'antigène COVID-19 RAMP de 15 minutes de haute qualité. La plateforme RAMP est basée sur la détection de la fluorescence et a démontré des performances similaires à la RCP dans le contexte de l'utilisateur final.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
121519920
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Response Biomedical Corp.
Recipient Operating Name
RBC
Recipient Postal Code
V6P 6P2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q3-960033
